The Repurposed Revolution: Why Off-Patent Drugs Are Challenging the $290 Billion Cancer Industry
Main Facts The modern oncology paradigm is facing an unprecedented intellectual and structural challenge. At the center of this friction is Dr. William Makis, a prominent Canadian-trained physician and researcher whose recent transition to practicing in Florida has reignited a fierce global debate over the integration of affordable, off-patent medications into advanced cancer care protocols….
